Steven A. Kriegsman, Director at RXI PHARMACEUTICALS CORP (RXII), sold 5,256 shares at $4.59 ($25K) on 2009-05-07, disclosed to the SEC on 2009-05-11.
Scheduled sale ($25k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.59 | 3,513 | $16K | 65.7% |
| 2 | $4.82 | 1,743 | $8K | 34.3% |
| Total | $4.67 avg | 5,256 | $25K | 100% |
| Filing → |
| CYTR | BUY | 2012-02-24 | $51K | — | Filing → |
| RXII | SELL | 2009-08-20 | $28K | — | Filing → |
| RXII | SELL | 2009-07-06 | $13K | — | Filing → |